• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非线性混合效应模型进行氧氟沙星的群体分析:年龄对口服药物药代动力学的影响。

Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: effects of age on oral drug pharmacokinetics.

作者信息

Yuen G J, Drusano G L, Brooks J, Flor S

机构信息

School of Pharmacy, Department of Clinical Pharmacy, University of Maryland Baltimore 21201.

出版信息

Pharmacotherapy. 1992;12(2):88-92.

PMID:1570232
Abstract

To compare the effect of age on pharmacokinetics of orally administered ofloxacin, two separate studies were reanalyzed using mixed-effect modeling with the program NONMEM. Subjects were male volunteers, 36 age 65 years or greater and 24 age 18-40 years. The younger group received three 100-mg tablets and the older group received two 200-mg tablets of ofloxacin. Serial blood samples obtained throughout dosing were assayed for drug concentrations using high-performance liquid chromatography. A pharmacostatistical model was developed for the data using mixed-effect modeling with NONMEM. A one-compartment open model with first-order absorption, which included the covariables weight and age, best fit the data. Mean (SE) population values were clearance/F 0.219 (0.009) L/hr/kg, volume of distribution/F 1.50 (0.071) L/kg, and absorption rate constant 2.26 (0.048) hr-1. Older subjects had a 29% lower clearance and 13% lower volume of distribution then the younger subjects.

摘要

为比较年龄对口服氧氟沙星药代动力学的影响,使用NONMEM程序通过混合效应模型对两项独立研究进行了重新分析。研究对象为男性志愿者,36名年龄在65岁及以上,24名年龄在18 - 40岁。较年轻组服用三片100毫克的氧氟沙星片剂,较年长组服用两片200毫克的氧氟沙星片剂。在整个给药过程中采集的系列血样使用高效液相色谱法测定药物浓度。使用NONMEM通过混合效应模型为数据建立了药物统计学模型。一个具有一级吸收的单室开放模型,其中包括协变量体重和年龄,最符合数据。平均(标准误)总体参数值为清除率/F 0.219(0.009)升/小时/千克,分布容积/F 1.50(0.071)升/千克,吸收速率常数2.26(0.048)小时⁻¹。年长受试者的清除率比年轻受试者低29%,分布容积低13%。

相似文献

1
Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: effects of age on oral drug pharmacokinetics.使用非线性混合效应模型进行氧氟沙星的群体分析:年龄对口服药物药代动力学的影响。
Pharmacotherapy. 1992;12(2):88-92.
2
[Pharmacokinetics of ofloxacin administered orally in elderly subjects with bronchial or urinary tract infections].[老年支气管或尿路感染患者口服氧氟沙星的药代动力学]
Therapie. 1992 Jan-Feb;47(1):35-9.
3
Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.两项开放标签、随机、交叉研究,评估了健康受试者中氧氟沙星速释和缓释制剂的生物等效性。
Clin Ther. 2006 Dec;28(12):2070-80. doi: 10.1016/j.clinthera.2006.12.018.
4
Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.小儿静脉注射对乙酰氨基酚(丙帕他莫)的药代动力学:一项群体分析。
Paediatr Anaesth. 2005 Apr;15(4):282-92. doi: 10.1111/j.1460-9592.2005.01455.x.
5
Pharmacokinetics and safety of single rising doses of ofloxacin in healthy volunteers.
Pharmacotherapy. 1992;12(1):45-9.
6
Pharmacokinetics and relative bioavailability of ofloxacin tablets in 12 healthy volunteers.氧氟沙星片在12名健康志愿者体内的药代动力学及相对生物利用度
Zhongguo Yao Li Xue Bao. 1992 Mar;13(2):110-2.
7
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.400毫克阿昔洛韦的两种口服混悬剂和两种口服片剂剂型的生物利用度:在健康墨西哥成年受试者中进行的两项单剂量、开放标签、随机、两期交叉比较。
Clin Ther. 2007 Jun;29(6):1146-52. doi: 10.1016/j.clinthera.2007.06.007.
8
Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.氧氟沙星在耐药结核病中的药代动力学。 需注意,原文中“Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.”多了一个“of”,正确表述应为“Pharmacokinetics of ofloxacin in drug-resistant tuberculosis” 。
J Med Assoc Thai. 2003 Aug;86(8):781-8.
9
Pharmacokinetics and tissue distribution of ofloxacin in human subjects during a multiple dose regimen.多剂量给药方案下氧氟沙星在人体受试者中的药代动力学及组织分布
Int J Clin Pharmacol Res. 1988;8(4):239-45.
10
Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.类风湿关节炎患者同时使用甲氨蝶呤时依那西普的药代动力学未改变。
J Clin Pharmacol. 2004 Nov;44(11):1235-43. doi: 10.1177/0091270004268049.

引用本文的文献

1
Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective.群体药代动力学在药物研发中的作用。制药行业视角。
Clin Pharmacokinet. 1997 Apr;32(4):294-312. doi: 10.2165/00003088-199732040-00003.
2
Identification of populations at risk in drug testing and therapy: application to elderly patients.
Eur J Drug Metab Pharmacokinet. 1993 Jan-Mar;18(1):101-11. doi: 10.1007/BF03220013.
3
Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.群体药代动力学分析中结构模型、统计模型和协变量模型之间的相互作用。
J Pharmacokinet Biopharm. 1994 Apr;22(2):165-77. doi: 10.1007/BF02353542.
4
Quinolone antibacterials. An update of their pharmacology and therapeutic use.喹诺酮类抗菌药。其药理学与治疗应用的最新进展。
Drugs. 1994 Jun;47(6):872-901. doi: 10.2165/00003495-199447060-00003.